Francisco Averhoff

Francisco Averhoff

Auto-generated profile, based on publicly available information

Francisco Averhoff

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2012 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
FAFrancisco M. Averhoff
Francisco M. Averhoff
NGNancy Glass
Nancy Glass
DHDeborah Holtzman
Deborah Holtzman
An estimated 2%–3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from 10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings. Hepatitis C prevention, care, and treatment programs must recognize country-specific epidemiology, which varies by setting and level of economic development. Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCV infection is endemic and for counseling patients who travel to these countries. Countries with a high burden of HCV infection also would benefit from establishing comprehensive prevention, care, and treatment programs.

1 June 2004 in American Journal of Public Health
Verified
Journal Article
Closed access
FAFrancisco Averhoff
Francisco Averhoff
LLLeslie Linton
Leslie Linton
KPK. Michael Peddecord
K. Michael Peddecord
CEChristine Edwards
Christine Edwards
WWWendy Wang
Wendy Wang
DFDaniel Fishbein
Daniel Fishbein
Objectives. This study assessed the effectiveness of a middle school vaccination requirement for raising second-dose measles, mumps, and rubella vaccine and hepatitis B vaccine coverage among adolescents. Methods. Random-digit-dialed telephone surveys were conducted before (1998) and after (1999) the implementation of a vaccination requirement for entry into the seventh grade in San Diego, Calif. Results. Vaccination coverage was higher among children subject to the vaccination requirement (seventh-grade students; 60%) than among fifth- and sixth-grade students 1 year before the requirement (13%, P < .001), and 8th- through 12th-grade students not subject to the requirement (27%, P < .0001). Conclusions. Middle school–entry vaccination requirements can rapidly and substantially raise vaccination coverage among students subject to the law.

10 May 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
LHLiesl M. Hagan
Liesl M. Hagan
AKAna Kasradze
Ana Kasradze
SSStephanie Salyer
Stephanie Salyer
AGAmiran Gamkrelidze
Amiran Gamkrelidze
MAMaia Alkhazashvili
Maia Alkhazashvili
FAFrancisco Averhoff
Francisco Averhoff
The country of Georgia launched the world’s first Hepatitis C Virus (HCV) Elimination Program in 2015 and set a 90% prevalence reduction goal for 2020. We conducted a nationally representative HCV seroprevalence survey to establish baseline prevalence to measure progress toward elimination over time. A cross-sectional seroprevalence survey was conducted in 2015 among adults aged ≥18 years using a stratified, multi-stage cluster design (n = 7000). Questionnaire variables included demographic, medical, and behavioral risk characteristics and HCV-related knowledge. Blood specimens were tested for antibodies to HCV (anti-HCV) and HCV RNA. Frequencies were computed for HCV prevalence, risk factors, and HCV-related knowledge. Associations between anti-HCV status and potential risk factors were calculated using logistic regression. National anti-HCV seroprevalence in Georgia was 7.7% (95% confidence interval (CI) = 6.7, 8.9); HCV RNA prevalence was 5.4% (95% CI = 4.6, 6.4). Testing anti-HCV+ was significantly associated with male sex, unemployment, urban residence, history of injection drug use (IDU), incarceration, blood transfusion, tattoos, frequent dental cleanings, medical injections, dialysis, and multiple lifetime sexual partners. History of IDU (adjusted odds ratio (AOR) = 21.4, 95% CI = 12.3, 37.4) and blood transfusion (AOR = 4.5, 95% CI = 2.8, 7.2) were independently, significantly associated with testing anti-HCV+ after controlling for sex, age, urban vs. rural residence, and history of incarceration. Among anti-HCV+ participants, 64.0% were unaware of their HCV status, and 46.7% did not report IDU or blood transfusion as a risk factor. Georgia has a high HCV burden, and a majority of infected persons are unaware of their status. Ensuring a safe blood supply, implementing innovative screening strategies beyond a risk-based approach, and intensifying prevention efforts among persons who inject drugs are necessary steps to reach Georgia’s HCV elimination goal.

4 December 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
FAFrancisco Averhoff
Francisco Averhoff
SSShaun Shadaker
Shaun Shadaker
AGAmiran Gamkrelidze
Amiran Gamkrelidze
TKTatia Kuchuloria
Tatia Kuchuloria
LGLia Gvinjilia
Lia Gvinjilia
MNMuazzam Nasrullah
Muazzam Nasrullah

6 December 2017 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
ATAdam Trickey
Adam Trickey
MMMargaret T. May
Margaret T. May
CDCharlotte Davies
Charlotte Davies
HQHuma Qureshi
Huma Qureshi
SHSaeed Hamid
Saeed Hamid
PVPeter Vickerman
Peter Vickerman
Pakistan has a high prevalence of hepatitis C virus (HCV) infection, estimated at 4.9% (2,290/46,843) in the 2007 national HCV seroprevalence survey. We used data from this survey to assess the importance of risk factor associations with HCV prevalence in Pakistan. Exposures were grouped as community (going to the barbers, sharing smoking equipment, having an ear/nose piercing, tattoo, or acupuncture), healthcare (ever having hemodialysis, blood transfusion, or ≥ 5 injections in the last year), demographic (marital status and age), and socio-economic (illiterate or laborer). We used mutually adjusted multivariable regression analysis, stratified by sex, to determine associations with HCV infection, their population attributable fraction, and how risk of infection accumulates with multiple exposures. Strength of associations was assessed using adjusted odds ratios (aOR). Community [aOR females 1.5 (95% confidence interval [CI]: 1.2, 1.8); males 1.2 (1.1, 1.4)] and healthcare [females 1.4 (1.2, 1.6); males 1.2 (1.1, 1.4)] exposures, low socio-economic status [females 1.6 (1.3, 1.80); males 1.3 (1.2, 1.5)], and marriage [females 1.5 (1.2, 1.9); males 1.4 (1.1, 1.8)] were associated with increased HCV infection. Among married women, the number of children was associated with an increase in HCV infection; linear trend aOR per child 1.06 (1.01, 1.11). Fewer infections could be attributed to healthcare exposures (females 13%; males 6%) than to community exposures (females 25%; males 9%). Prevalence increased from 3% to 10% when cumulative exposures increased from 1 to ≥ 4 [aOR per additional exposure for females 1.5 (1.4, 1.6); males 1.2 (1.2, 1.3)]. A combination of community, healthcare, and other factors appear to drive the Pakistan HCV epidemic, highlighting the need for a comprehensive array of prevention strategies.

1 November 2006 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
FAFrancisco Averhoff
Francisco Averhoff
JZJane Zucker
Jane Zucker
CVClaudia Vellozzi
Claudia Vellozzi
SRSusan Redd
Susan Redd
CWCelia Woodfill
Celia Woodfill
SRSusan E. Reef
Susan E. Reef
Background.Reported rubella cases in the United States are at the lowest numbers since the introduction of vaccine, suggesting that endemic transmiss